Loading...
EXMceuticals Inc.
EXM.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.20
CA$0.00(0.00%)

Over the past four quarters, EXMceuticals Inc. demonstrated steady revenue growth, increasing from $0.00 in Q4 2019 to $0.00 in Q3 2020. Operating income reached -$2.39M in Q3 2020, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$2.36M, reflecting operational efficiency. Net income dropped to -$2.48M, with EPS at -$0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan